The Experts below are selected from a list of 810 Experts worldwide ranked by ideXlab platform
Patrick C Cartwright - One of the best experts on this subject based on the ideXlab platform.
-
bilateral Testis tumors in an infant synchronous Teratoma and epidermoid cyst
The Journal of Urology, 1995Co-Authors: John T Mansfield, Patrick C CartwrightAbstract:Teratoma ranks second in frequency to yolk sac carcinoma among testicular germ cell tumors in infants, accounting for 25% of cases. Testicular Teratomas are uniformly benign in children younger than 24 months old. Epidermoid cysts are tumor-like lesions of unknown etiology, probably monodermal Teratomas, comprising 3% of all pediatric Testis tumors. Bilaterality is rare for both tumors. We report a case of a synchronous left Testis Teratoma and a right Testis epidermoid cyst. Appropriate therapy is discussed.
-
pediatric articles bilateral Testis tumors in an infant synchronous Teratoma and epidermoid cyst
The Journal of Urology, 1995Co-Authors: John T Mansfield, Patrick C CartwrightAbstract:ABSTRACTTeratoma ranks second in frequency to yolk sac carcinoma among testicular germ cell tumors in infants, accounting for 25% of cases. Testicular Teratomas are uniformly benign in children younger than 24 months old. Epidermoid cysts are tumor-like lesions of unknown etiology, probably monodermal Teratomas, comprising 3% of all pediatric Testis tumors. Bilaterality is rare for both tumors. We report a case of a synchronous left Testis Teratoma and a right Testis epidermoid cyst. Appropriate therapy is discussed.
John T Mansfield - One of the best experts on this subject based on the ideXlab platform.
-
bilateral Testis tumors in an infant synchronous Teratoma and epidermoid cyst
The Journal of Urology, 1995Co-Authors: John T Mansfield, Patrick C CartwrightAbstract:Teratoma ranks second in frequency to yolk sac carcinoma among testicular germ cell tumors in infants, accounting for 25% of cases. Testicular Teratomas are uniformly benign in children younger than 24 months old. Epidermoid cysts are tumor-like lesions of unknown etiology, probably monodermal Teratomas, comprising 3% of all pediatric Testis tumors. Bilaterality is rare for both tumors. We report a case of a synchronous left Testis Teratoma and a right Testis epidermoid cyst. Appropriate therapy is discussed.
-
pediatric articles bilateral Testis tumors in an infant synchronous Teratoma and epidermoid cyst
The Journal of Urology, 1995Co-Authors: John T Mansfield, Patrick C CartwrightAbstract:ABSTRACTTeratoma ranks second in frequency to yolk sac carcinoma among testicular germ cell tumors in infants, accounting for 25% of cases. Testicular Teratomas are uniformly benign in children younger than 24 months old. Epidermoid cysts are tumor-like lesions of unknown etiology, probably monodermal Teratomas, comprising 3% of all pediatric Testis tumors. Bilaterality is rare for both tumors. We report a case of a synchronous left Testis Teratoma and a right Testis epidermoid cyst. Appropriate therapy is discussed.
Jianmin Wang - One of the best experts on this subject based on the ideXlab platform.
-
stage i Testis Teratoma in adults treatment options and recurrence factors
National journal of andrology, 2011Co-Authors: Shimiao Zhu, Qiong Pei, Yang Tang, Linguo Xie, Xiaofei Dai, Guang Sun, Ruifa Han, Jianmin WangAbstract:OBJECTIVE: To study the clinical outcomes of stage I Testis Teratoma, including pure Teratoma, and to provide information on the treatment options for this disease. METHODS: We retrospectively analyzed 27 cases of orchiectomy for stage I Testis Teratoma, excluding epidermoid cyst, and investigated its recurrence associated with treatment methods and clinicopathological factors. RESULTS: Four of the 27 cases relapsed, all in the orchiectomy group and confined to the retroperitoneal region, 3 with and the other 1 without risk factors, but with no death. No recurrence was found in those treated by orchiectomy followed by chemotherapy with bleomycin, etoposide and platinum (BEP). The total rate of recurrence was 15.8%. No severe side effects were observed in the 9 patients undergoing adjuvant BEP chemotherapy. CONCLUSION: Risk factors may increase the recurrence rate of stage I Testis Teratoma, while postoperative adjuvant chemotherapy can reduce it, including that of pure Teratoma, though surveillance policy remains the most popular option after orchiectomy.
Shimiao Zhu - One of the best experts on this subject based on the ideXlab platform.
-
stage i Testis Teratoma in adults treatment options and recurrence factors
National journal of andrology, 2011Co-Authors: Shimiao Zhu, Qiong Pei, Yang Tang, Linguo Xie, Xiaofei Dai, Guang Sun, Ruifa Han, Jianmin WangAbstract:OBJECTIVE: To study the clinical outcomes of stage I Testis Teratoma, including pure Teratoma, and to provide information on the treatment options for this disease. METHODS: We retrospectively analyzed 27 cases of orchiectomy for stage I Testis Teratoma, excluding epidermoid cyst, and investigated its recurrence associated with treatment methods and clinicopathological factors. RESULTS: Four of the 27 cases relapsed, all in the orchiectomy group and confined to the retroperitoneal region, 3 with and the other 1 without risk factors, but with no death. No recurrence was found in those treated by orchiectomy followed by chemotherapy with bleomycin, etoposide and platinum (BEP). The total rate of recurrence was 15.8%. No severe side effects were observed in the 9 patients undergoing adjuvant BEP chemotherapy. CONCLUSION: Risk factors may increase the recurrence rate of stage I Testis Teratoma, while postoperative adjuvant chemotherapy can reduce it, including that of pure Teratoma, though surveillance policy remains the most popular option after orchiectomy.
Linguo Xie - One of the best experts on this subject based on the ideXlab platform.
-
stage i Testis Teratoma in adults treatment options and recurrence factors
National journal of andrology, 2011Co-Authors: Shimiao Zhu, Qiong Pei, Yang Tang, Linguo Xie, Xiaofei Dai, Guang Sun, Ruifa Han, Jianmin WangAbstract:OBJECTIVE: To study the clinical outcomes of stage I Testis Teratoma, including pure Teratoma, and to provide information on the treatment options for this disease. METHODS: We retrospectively analyzed 27 cases of orchiectomy for stage I Testis Teratoma, excluding epidermoid cyst, and investigated its recurrence associated with treatment methods and clinicopathological factors. RESULTS: Four of the 27 cases relapsed, all in the orchiectomy group and confined to the retroperitoneal region, 3 with and the other 1 without risk factors, but with no death. No recurrence was found in those treated by orchiectomy followed by chemotherapy with bleomycin, etoposide and platinum (BEP). The total rate of recurrence was 15.8%. No severe side effects were observed in the 9 patients undergoing adjuvant BEP chemotherapy. CONCLUSION: Risk factors may increase the recurrence rate of stage I Testis Teratoma, while postoperative adjuvant chemotherapy can reduce it, including that of pure Teratoma, though surveillance policy remains the most popular option after orchiectomy.